Q-omics provides the consensus-scored TMSB4XP3 profile across patient tissues and cancer cell-line models. TMSB4XP3 expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in UCEC. Among the 18 cancer types available for tumor–normal comparison, TMSB4XP3 is differentially expressed in 2, with the highest sampling consensus in THCA. Additionally, TMSB4XP3 RNA expression shows 6,615 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight UCEC, THCA, and STAD as cancer lineages where TMSB4XP3 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for TMSB4XP3 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes TMSB4XP3 survival associations across molecular data types. TMSB4XP3 RNA expression shows survival associations in the most cancer types (16). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible TMSB4XP3 RNA expression–survival associations across cancer types. High TMSB4XP3 expression shows unfavorable associations in UCEC, KIRP, LUAD, COAD, LIHC and DLBC. The UCEC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .006). Together, the overview and detailed table identify UCEC as the clearest survival context for TMSB4XP3 RNA expression.
This table summarizes TMSB4XP3 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 2. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for TMSB4XP3. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. TMSB4XP3 shows higher tumor expression in THCA and BRCA. The THCA box plot shows higher TMSB4XP3 RNA expression in tumor versus normal tissue (log2 FC = +0.923, t-test p < 0.001).
This table shows molecular features associated with TMSB4XP3 in patient tissues and cancer cell lines. In patient samples, TMSB4XP3 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
